000			01976 a2200589 4500
005			20250515073609.0
264		0	_c20071227
008			200712s 0 0 eng d
022			_a1476-5551
024	7		_a10.1038/sj.leu.2404828 _2doi
040			_aNLM _beng _cNLM
100	1		_aOran, B
245	0	0	_aTreatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation. _h[electronic resource]
260			_bLeukemia _cDec 2007
300			_a2540-4 p. _bdigital
500			_aPublication Type: Comparative Study; Letter
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCombined Modality Therapy
650	0	4	_aFemale
650	0	4	_aHematopoietic Stem Cell Transplantation _xstatistics & numerical data
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadministration & dosage
650	0	4	_aLeukemia, Myeloid, Acute _xdrug therapy
650	0	4	_aLymphocyte Transfusion _xstatistics & numerical data
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyeloablative Agonists _xadministration & dosage
650	0	4	_aMyelodysplastic Syndromes _xdrug therapy
650	0	4	_aPalliative Care
650	0	4	_aRecurrence
650	0	4	_aRemission Induction
650	0	4	_aSalvage Therapy
650	0	4	_aTransplantation Conditioning _xmethods
650	0	4	_aTransplantation, Homologous
700	1		_aGiralt, S
700	1		_aCouriel, D
700	1		_aHosing, C
700	1		_aShpall, E J
700	1		_ade Meis, E
700	1		_aKhouri, I F
700	1		_aQazilbash, M
700	1		_aAnderlini, P
700	1		_aKebriaei, P
700	1		_aPopat, U
700	1		_aCarrasco-Yalan, A
700	1		_aChamplin, R E
700	1		_ade Lima, M
773	0		_tLeukemia _gvol. 21 _gno. 12 _gp. 2540-4
856	4	0	_uhttps://doi.org/10.1038/sj.leu.2404828 _zAvailable from publisher's website
999			_c17147528 _d17147528